Core and Group Health

Roughly 5.1% of U.S. adults may now be using GLP-1 agonists to try to control their weight, according to eHealth.

“While many Americans are satisfied with their coverage options for 2026, many are facing significant cost increases and less rich benefits,” said Derrick Duke, CEO of eHealth.

The American Hospital Association and Maine Hospital Association on Monday filed a lawsuit in U.S. District Court in Maine to stop upcoming changes to the federal 340B Drug Pricing Program.

Plans could still use strategies other than prior authorization reviews to cut down on unnecessary use of care.

The Blue Cross and Blue Shield carrier told California providers that maintaining accurate practice information is a contractual requirement.

Judge Quraishi ruled that the connection between premiums paid by plan participants and out-of-pocket costs and the administrative fees the plans paid to their pharmacy benefit manager was “speculative.”